1Krishnan E, Kwoh CK, Schumacher HR, et al. Hyperuricernia and incidence of hypertension among men without metabolic syndrome [J]. Hypertension,2007,49(2) :298 303.
2Onat A, Uyarel H, Hergenc G, et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study [J]. Am J Hypertens,2006,19(10):1055 1062.
3Kackov S, Simundic AM, Nikolac N, et al. The association of uric acid with glucose and lipids in general population: Croatian cross-sectional study[J]. Coil Antropol, 2011, 35 (4): 1055 1059.
7Shatat IF,Abdallah RT,Sas DJ,et al. Serum uric acid in U. S. adolescents., distribution and relationship to demographic characteristics and cardiovascular risk factors [J]. Pediatric Research,2012 Mar 30. doi; 10. 1038/pr. 2012.47. [Epub ahead of print].
6Dobiasova M, Frohlich J. The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy. Vnitr Lek, 2000, 46: 152-156.
7Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem, 2001, 34: 583-588.
8Lai SW, Li TC, Ng KC. Hyperuricaemia and its related factors in Taiwan Residents middle-aged adults. Int J Nurs Praet, 2002, 8 : 56-60.
9Frost PH Ratinal for use of non-HDL cholesterol rather than LDI cholesterol as tool for lipoprotein cholester-ol screening and assessment of risk and therapy. Am J Cardiol, 1998, 81:26B.
10Grundy SM. Hypcrtriglyccridcnia, athcrogcnic dyslipdcrnia and the metabolic syndrome. AJH J Cardiel, 1998,814 : 1R-23B.
